Recent Development in Carbohydrate Based Anticancer Vaccines

REFERENCES

• Siegel , R. , Naishadham , D. and Jemal , A. 2012 . Cancer statistics, 2012 . CA Cancer J. Clin. , 62 : 10 – 29 .
   PubMed Web of Science ®Google Scholar
• Jemal , A. , Bray , F. , Center , M. M. , Ferlay , J. , Ward , E. and Forman , D. 2011 . Global cancer statistics . CA Cancer J. Clin. , 61 : 69 – 90 .
   PubMed Web of Science ®Google Scholar
• Coley , W. B. 1991 . The classic - the treatment of malignant-tumors by repeated inoculations of erysipelas - with a report of 10 original cases . Clin. Orthop. Relat. Res. , 262 : 3 – 11 .
   PubMedGoogle Scholar
• Burnet , M. 1957 . Cancer-a biological approach . Brit. Med. J. , 1 : 841 – 847 .
   PubMed Web of Science ®Google Scholar
• Grillo-Lopez , A. J. , Hedrick , E. , Rashford , M. and Benyunes , M. 2002 . Rituximab: ongoing and future clinical development . Semin. Oncol. , 29 : 105 – 112 .
   PubMed Web of Science ®Google Scholar
• Weiner , L. M. , Surana , R. and Wang , S. 2010 . Monoclonal antibodies: versatile platforms for cancer immunotherapy . Nat. Rev. Immunol. , 10 : 317 – 327 .
   PubMed Web of Science ®Google Scholar
• Danishefsky , S. J. and Allen , J. R. 2000 . From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate-based anticancer vaccines . Angew. Chem. Int. Ed. , 39 : 836 – 863 . and references cited therein
   PubMed Web of Science ®Google Scholar
• Hakomori , S. and Zhang , Y. 1997 . Glycosphingolipid antigens and cancer therapy . Chem. Biol. , 4 : 97 – 104 .
   PubMed Web of Science ®Google Scholar
• Hakomori , S. 1996 . Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism . Cancer Res. , 56 : 5309 – 5318 .
   PubMed Web of Science ®Google Scholar
• Nores , G. A. , Dohi , T. , Taniguchi , M. and Hakomori , S. 1987 . Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen . J. Immunol. , 139 : 3171 – 3176 .
   PubMed Web of Science ®Google Scholar
• Cheever , M. A. , Allison , J. P. , Ferris , A. S. , Finn , O. J. , Hastings , B. M. , Hecht , T. T. , Mellman , I. , Prindiville , S. A. , Viner , J. L. , Weiner , L. M. and Matrisian , L. M. 2009 . The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research . Clin. Cancer Res. , 15 : 5323 – 5337 .
   PubMed Web of Science ®Google Scholar
• Hakomori , S. 2001 . Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines . Adv. Exp. Med. Biol. , 491 : 369 – 402 .
   PubMed Web of Science ®Google Scholar
• Livingston , P. O. , Zhang , S. and Lloyd , K. O. 1997 . Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale . Cancer Immunol. Immunother. , 45 : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Hamilton , W. B. , Helling , F. , Lloyd , K. O. and Livingston , P. O. 1993 . Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography . Int. J. Cancer , 53 : 566 – 573 .
   PubMed Web of Science ®Google Scholar
• Huang , C.-Y. , Thayer , D. A. , Chang , A. Y. , Best , M. D. , Hoffmann , J. , Head , S. and Wong , C. H. 2006 . Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen . Proc. Nat. Acad. Sci. USA , 103 : 15 – 20 .
   PubMed Web of Science ®Google Scholar
• Kudryashov , V. , Glunz , P. W. , Williams , L. J. , Hintermann , S. , Danishefsky , S. J. and Lloyd , K. O. 2001 . Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewisy conjugates in mice . Proc. Nat. Acad. Sci. USA , 98 : 3264 – 3268 .
   PubMed Web of Science ®Google Scholar
• Zhou , B. B. , Zhang , H. , Damelin , M. , Geles , K. G. , Grindley , J. C. and Dirks , P. B. 2009 . Tumour-initiating cells: challenges and opportunities for anticancer drug discovery . Nat. Rev. Drug Discov. , 8 : 806 – 23 .
   PubMed Web of Science ®Google Scholar
• Lin , W.-M. , Karsten , U. , Goletz , S. , Cheng , R.-C. and Cao , Y. 2010 . Co-expression of CD173 (H2) and CD174 (Lewis y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells . Vischow Arch. , 456 : 403 – 409 .
   Web of Science ®Google Scholar
• Chang , W.-W. , Lee , C. H. , Lee , P. , Lin , J. , Hsu , C.-W. , Hung , J.-T. , Lin , J.-J. , Yu , J.-C. , Shao , L.-e. , Yu , J. , Wong , C.-H. and Yu , A. L. 2008 . Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis . Proc. Natl. Acad. Sci. USA , 105 : 11667 – 11672 .
   PubMed Web of Science ®Google Scholar
• Goldsby , R. A. , Kindt , T. J. and Osborne , B. A. 2000 . “ B-cell Generation, Activation, and Differentiation ” . In Kuby Immunology , 275 – 285 . New York : Freeman .
   Google Scholar
• Bretscher , P. and Cohn , M. 1970 . A theory of self-nonself discrimination: paralysis and induction involve the recognition of one and two determinants on an antigen, respectively . Science , 169 : 1042 – 1049 .
   PubMed Web of Science ®Google Scholar
• Livingston , P. O. , Wong , G. Y.C. , Adluri , S. , Tao , Y. , Padavan , M. , Parente , R. , Hanlon , C. , Calves , M. J. , Helling , F. , Ritter , G. , Oettgen , H. F. and Old , L. J. 1994 . Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside . J. Clin. Oncol. , 12 : 1036 – 1044 .
   PubMed Web of Science ®Google Scholar
• Jones , P. C. , Sze , L. L. , Liu , P. Y. , Morton , D. L. and Irie , R. F. 1981 . Prolonged survival for melanoma patients with elevated igm antibody to oncofetal antigen . J. Nat. Cancer Inst. , 66 : 249 – 254 .
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj , S. , Cordon-Cardo , C. , Carswell , E. , Mintzer , D. , Dantis , L. , Duteau , C. , Templeton , M. A. , Oettgen , H. F. , Old , L. J. and Houghton , A. N. 1988 . Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites . J. Clin. Oncol. , 6 : 1636 – 1648 .
   PubMed Web of Science ®Google Scholar
• Nasi , M. L. , Meyers , M. , Livingston , P. O. , Houghton , A. N. and Chapman , P. B. 1997 . Anti-melanoma effects of r24, a monoclonal antibody against GD3 ganglioside . Melanoma Res. , 7 : S155 – S162 .
   Web of Science ®Google Scholar
• Kuberan , B. and Linhardt , R. J. 2000 . Carbohydrate based vaccines . Curr. Org. Chem. , 4 : 635 – 677 .
   Google Scholar
• Filion , M. C. and Phillips , N. C. 2001 . Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations . J. Pharm. Pharmacol. , 53 : 555 – 561 .
   Web of Science ®Google Scholar
• Galonic , D. P. and Gin , D. Y. 2007 . Chemical glycosylation in the synthesis of glycoconjugate antitumor vaccines . Nature , 446 : 1000 – 1007 .
   PubMed Web of Science ®Google Scholar
• Hsu , C.-H. , Hung , S.-C. , Wu , C.-Y. and Wong , C.-H. 2011 . Toward automated oligosaccharide synthesis . Angew. Chem. Int. Ed. , 50 : 11872 – 11923 .
   PubMed Web of Science ®Google Scholar
• Wang , Z. and Huang , X. 2007 . “ Strategies in oligosaccharide synthesis ” . In Comprehensive Glycoscience from Chemistry to Systems Biology , Edited by: Kamerling , J. P. Vol. 1 , 379 – 413 . Amsterdam : Elsevier .
   Google Scholar
• Icart , L. P. , Fernandez-Santana , V. , Veloso , R. C. , Carmenate , T. , Sirois , S. , Roy , R. and Bencomo , V. V. 2008 . “ T-cell immunity of carbohydrates ” . In Carbohydrate-Based Vaccines , ACS symposium series, 989 Edited by: Roy , R. 1 – 19 . Washington , D.C. : American Chemical Society .
   Google Scholar
• Helling , F. , Shang , A. , Calves , M. , Zhang , S. , Ren , S. , Yu , R. K. , Oettgen , H. E. and Livingston , P. O. 1994 . GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines . Cancer Res. , 54 : 197 – 203 .
   PubMed Web of Science ®Google Scholar
• Livingston , P. O. , Ritter , G. , Srivastava , P. , Padavan , M. , Calves , M. J. , Oettgen , H. E. and Old , L. J. 1989 . Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside . Cancer Res. , 49 : 7045 – 7050 .
   PubMed Web of Science ®Google Scholar
• Livingston , P. O. , Natoli , E. J.J. , Calves , M. J. , Stockert , E. and Oettgen , H. F. 1987 . Old Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients . Proc. Natl. Acad. Sci. USA , 84 : 2911 – 2915 .
   PubMed Web of Science ®Google Scholar
• Vliegenthart , J. F.G. 2006 . Carbohydrate based vaccines . FEBS Lett. , 580 : 2945 – 2950 .
   PubMed Web of Science ®Google Scholar
• Freire , T. , Bay , S. , Vichier-Guerre , S. , Lo-Man , R. and Leclerc , C. 2006 . Carbohydrate antigens: synthesis aspects and immunological applications in cancer . Mini-Rev. Med. Chem. , 6 : 1357 – 1373 .
   PubMed Web of Science ®Google Scholar
• Roy , R. 2004 . New trends in carbohydrate-based vaccines . Drug Disc. Today Technologies , 1 : 327 – 336 .
   PubMedGoogle Scholar
• Liakatos , A. and Kunz , H. 2007 . Synthetic glycopeptides for the development of cancer vaccines . Curr. Opin. Mol. Therap. , 9 : 35 – 44 .
   Web of Science ®Google Scholar
• Livingston , P. O. and Ragupathi , G. 1997 . Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans . Cancer Immunol. Immunother. , 45 : 10 – 19 .
   PubMed Web of Science ®Google Scholar
• Germain , R. N. 1994 . MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation . Cell , 76 : 287 – 299 .
   PubMed Web of Science ®Google Scholar
• Dintzis , H. M. , Dintzis , R. Z. and Vogelstein , B. 1976 . Molecular determinants of immunogenicity: the immuno model of immune response . Proc. Nat. Acad. Sci. USA , 73 : 3671 – 3675 .
   PubMed Web of Science ®Google Scholar
• Denis , J. , Majeau , N. , Acosta-Ramirez , E. , Savard , C. , Bedard , M.-C. , Simard , S. , Lecours , K. , Bolduc , M. , Pare , C. , Willems , B. , Shoukry , N. , Tessier , P. , Lacasse , P. , Lamarre , A. , Lapointe , R. , Lopez Macias , C. and Leclerc , D. 2007 . Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization . Virology , 363 : 59 – 68 .
   PubMed Web of Science ®Google Scholar
• Jegerlehner , A. , Storni , T. , Lipowsky , G. , Schmid , M. , Pumpens , P. and Bachmann , M. F. 2002 . Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation . Eur. J. Immunol. , 32 : 3305 – 3314 .
   PubMed Web of Science ®Google Scholar
• Bachmann , M. F. , Hengartner , H. and Zinkernagel , R. M. 1995 . T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? . Eur. J. Immunol. , 25 : 3445 – 3451 .
   PubMed Web of Science ®Google Scholar
• Bachmann , M. F. and Zinkernagel , R. M. 1997 . Neutralizing antiviral B cell responses . Annu. Rev. Immunol. , 15 : 235 – 270 .
   PubMed Web of Science ®Google Scholar
• Bachmann , M. F. , Rohrer , U. H. , Kundig , T. M. , Burki , K. , Hengartner , H. and Zinkernagel , R. M. 1993 . The influence of antigen organization on B cell responsiveness . Science , 262 : 1448 – 1451 .
   PubMed Web of Science ®Google Scholar
• Germain , R. N. and Margulies , D. H. 1993 . The biochemistry and cell biology of antigen processing and presentation . Annu. Rev. Immunol. , 11 : 403 – 450 .
   PubMed Web of Science ®Google Scholar
• Haurum , J. S. , Arsequell , G. , Lellouch , A. C. , Wong , S. Y. , Dwek , R. A. , McMichael , A. J. and Elliott , T. 1994 . Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic t lymphocytes . J. Exp. Med. , 180 : 739 – 44 .
   PubMed Web of Science ®Google Scholar
• Abdel-Motal , U. M. , Berg , L. , Rosen , A. , Bengtsson , M. , Thorpe , C. J. , Kihlberg , J. , Dahmen , J. , Magnusson , G. , Karlsson , K. A. and Jondal , M. 1996 . Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells . Eur. J. Immunol. , 26 : 544 – 451 .
   Web of Science ®Google Scholar
• Speir , J. A. , Abdel-Motal , U. M. , Jondal , M. and Wilson , I. A. 1999 . Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL . Immunity , 10 : 51 – 61 .
   PubMed Web of Science ®Google Scholar
• Dengjel , J. , Rammensee , H. G. and Stevanovic , S. 2005 . Glycan side chains on naturally presented MHC class II ligands . J. Mass Spectrom. , 40 : 100 – 104 .
   PubMed Web of Science ®Google Scholar
• Dudler , T. , Altmann , F. , Carballido , J. M. and Blaser , K. 1995 . Carbohydrate-dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients . Eur. J. Immunol. , 25 : 538 – 542 .
   Web of Science ®Google Scholar
• Ando , S. , Yu , R. K. , Scarsdale , J. N. , Kusunoki , S. and Prestegard , J. H. 1989 . High resolution proton NMR studies of gangliosides. Structure of two types of GD3 lactones and their reactivity with monoclonal antibody R24 . J. Biol. Chem. , 264 : 3478 – 3483 .
   Web of Science ®Google Scholar
• Ritter , G. , Boosfeld , E. , Calves , M. J. , Oettgen , H. F. , Old , L. J. and Livingston , P. O. 1990 . Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse . Immunobiology , 182 : 32 – 43 .
   Web of Science ®Google Scholar
• Ritter , G. , Boosfeld , E. , Adluri , R. , Calves , M. , Oettgen , H. F. , Old , L. J. and Livingston , P. 1991 . Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma . Int. J. Cancer , 48 : 379 – 385 .
   PubMed Web of Science ®Google Scholar
• Ragupathi , G. , Meyers , M. , Adluri , S. , Howard , L. , Musselli , C. and Livingston , P. O. 2000 . Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-klh conjugate plus immunological adjuvant QS-21 . Int. J. Cancer , 85 : 659 – 666 .
   PubMed Web of Science ®Google Scholar
• Kawashima , I. , Kotani , M. , Ozawa , H. , Suzuki , M. and Tai , T. 1994 . Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells . Int. J. Cancer , 58 : 263 – 268 .
   Web of Science ®Google Scholar
• Maggio , B. , Ariga , T. and Yu , R. K. 1990 . Ganglioside GD3 lactones: polar head group mediated control of the intermolecular organization . Biochemistry , 29 : 8729 – 8734 .
   Web of Science ®Google Scholar
• Ding , K. , Rosen , A. , Ray , A. K. and Magnusson , G. 1992 . Anti-GM3-lactam monoclonal antibodies of the IgG type recognize natural GM3-ganglioside lactone but not GM3-ganglioside . Glycoconjugate J. , 9 : 303 – 306 .
   Web of Science ®Google Scholar
• Arcangeli , A. , Toma , L. , Contiero , L. , Crociani , O. , Legnani , L. , Lunghi , C. , Nesti , E. , Moneti , G. , Richichi , B. and Nativi , C. 2010 . Stable GM3 lactone mimetic raises antibodies specific for the antigens expressed on melanoma cells . Bioconjugate Chem. , 21 : 1432 – 1438 .
   Web of Science ®Google Scholar
• Kohla , G. , Stockfleth , E. and Schauer , R. 2002 . Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin . Neurochem. Res. , 27 : 583 – 592 .
   Web of Science ®Google Scholar
• Cheresh , D. A. , Reisfeld , R. A. and Varki , A. P. 1984 . O-Acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant . Science , 225 : 844 – 6 .
   PubMed Web of Science ®Google Scholar
• Ritter , G. , Ritter-Boosfeld , E. , Adluri , R. , Calves , M. , Ren , S. , Yu , R. K. , Oettgen , H. F. , Old , L. J. and Livingston , P. O. 1995 . Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma . Int. J. Cancer , 62 : 668 – 672 .
   Web of Science ®Google Scholar
• Schauer , R. 2000 . Achievements and challenges of sialic acid research . Glycoconjugate J. , 17 : 485 – 499 .
   PubMed Web of Science ®Google Scholar
• Irie , A. , Koyama , S. , Kozutsumi , Y. , Kawasaki , T. and Suzuki , A. 1998 . The molecular basis for the absence of N-glycolylneuraminic acid in humans . J. Biol. Chem. , 273 : 15866 – 71 .
   PubMed Web of Science ®Google Scholar
• Malykh , Y. N. , Schauer , R. and Shaw , L. 2001 . N-Glycolylneuraminic acid in human tumours . Biochimie , 83 : 623 – 634 .
   PubMed Web of Science ®Google Scholar
• de Leon , J. , Fernandez , A. , Mesa , C. , Clavel , M. and Fernandez , L. E. 2006 . Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells . Cancer Immunol. Immunother. , 55 : 443 – 450 .
   PubMed Web of Science ®Google Scholar
• Nakarai , H. , Chandler , P. J. , Kano , K. , Morton , D. L. and Irie , R. F. 1990 . Hanganutziu-deicher antigen as a possible target for immunotherapy of melanoma . Int. Arch. Allergy Appl. Immunol. , 91 : 323 – 328 .
   PubMedGoogle Scholar
• Fernandez , L. E. , Alonso , D. F. , Gomez , D. E. and Vazquez , A. M. 2003 . Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer . Expert Rev. Vaccines , 2 : 817 – 823 .
   Google Scholar
• Osorio , M. , Gracia , E. , Rodriguez , E. , Saurez , G. , Arango Mdel , C. , Noris , E. , Torriella , A. , Joan , A. , Gomez , E. , Anasagasti , L. , Gonzalez , J. L. , Melgares Mde , L. , Torres , I. , Gonzalez , J. , Alonso , D. , Rengifo , E. , Carr , A. , Perez , R. and Fernandez , L. E. 2008 . Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a phase Ib/IIa study . Cancer Biol. Ther. , 7 : 488 – 495 .
   PubMed Web of Science ®Google Scholar
• Weïwer , M. , Huang , F. , Chen , C.-C. , Yuan , X. , Tokuzaki , K. , Tomiyama , H. and Linhardt , R. J. 2008 . “ Synthesis and evaluation of anticancer vaccine candidates, c-glycoside analogs of STn and PSA ” . In Chemical glycobiology , Edited by: Chen , X. , Halcomb , R. L. and Wang , P. G. 216 – 238 . Washington , D.C. : American Chemical Society .
   Google Scholar
• Bundle , D. R. , Rich , J. R. , Jacques , S. , Yu , H. N. , Nitz , M. and Ling , C.-C. 2005 . Thiooligosaccharide conjugate vaccines evoke antibodies specific for native antigens . Angew. Chem. Int. Ed. , 44 : 7725 – 7729 .
   Web of Science ®Google Scholar
• Kuberan , B. , Sikkander , S. A. , Tomiyama , H. and Linhardt , R. J. 2003 . Synthesis of a C-glycoside analogue of STn: an HIV- and tumor-associated antigen . Angew. Chem. Int. Ed. , 42 : 2073 – 2075 .
   Web of Science ®Google Scholar
• Yang , F. , Zheng , X. J. , Huo , C. X. , Wang , Y. , Zhang , Y. and Ye , X. S. 2011 . Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of stn antigen . ACS Chem. Biol. , 6 : 252 – 259 .
   Web of Science ®Google Scholar
• Hoffmann-Röder , A. , Kaiser , A. , Wagner , S. , Gaidzik , N. , Kowalczyk , D. , Westerlind , U. , Gerlitzki , B. , Schmitt , E. and Kunz , H. 2010 . Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue . Angew. Chem. Int. Ed. , 49 : 8498 – 8503 .
   PubMed Web of Science ®Google Scholar
• Kayser , H. , Zeitler , R. , Kannicht , C. , Grunow , D. , Nuck , R. and Reutter , W. 1992 . Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors . J. Biol. Chem. , 267 : 16934 – 16938 .
   PubMed Web of Science ®Google Scholar
• Lemieux , G. A. and Bertozzi , C. R. 2001 . Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens . Chem. Biol. , 8 : 265 – 275 .
   PubMed Web of Science ®Google Scholar
• Liu , T. , Guo , Z. , Yang , Q. , Sad , S. and Jennings , H. J. 2000 . Biochemical engineering of surface a2–8 polysialic acid for immunotargeting tumor cells . J. Biol. Chem. , 275 : 32832 – 32836 .
   Web of Science ®Google Scholar
• Zou , W. , Borrelli , S. , Gilbert , M. , Liu , T. , Pon , R. A. and Jennings , H. J. 2004 . Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells . J. Biol. Chem. , 279 : 25390 – 25399 .
   Web of Science ®Google Scholar
• Pan , Y. , Chefalo , P. , Nagy , N. , Harding , C. and Guo , Z. 2005 . Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines . J. Med. Chem. , 48 : 875 – 883 .
   PubMed Web of Science ®Google Scholar
• Chefalo , P. , Pan , Y. , Nagy , N. , Guo , Z. and Harding , C. V. 2006 . Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine . Biochemistry , 45 : 3733 – 3739 .
   PubMed Web of Science ®Google Scholar
• Wang , Q. , Zhang , J. and Guo , Z. 2007 . Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell . Bioorg. Med. Chem. , 15 : 7561 – 7567 .
   PubMed Web of Science ®Google Scholar
• Yu , S. , Wang , Q. , Zhang , J. , Wu , Q. and Guo , Z. 2011 . Synthesis and evaluation of protein conjugates of GM3 derivatives carrying modified sialic acids as highly immunogenic cancer vaccine candidates . Medchemcomm , 2 : 524 – 530 .
   Web of Science ®Google Scholar
• Wang , Q. and Guo , Z. 2011 . Synthetic and immunological studies of STn derivatives carrying 5-N-(p-substituted phenylacetyl)sialic acid for the development of effective cancer vaccines . ACS Med. Chem. Lett. , 2 : 373 – 378 .
   Web of Science ®Google Scholar
• Lansteiner , K. and Chase , M. W. 1942 . Experiments on transfer of cutaneous sensitivity to simple compounds . Proc. Soc. Exp. Biol. Med , 49 : 688 – 690 .
   Google Scholar
• Bremer , E. G. , Levery , S. B. , Sonnino , S. , Ghidoni , R. , Canevari , S. , Kannagi , R. and Hakomori , S. 1984 . Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland . J. Biol. Chem. , 259 : 14773 – 14777 .
   PubMed Web of Science ®Google Scholar
• Zhang , S. , Cordon-Cardo , C. , Zhang , H. S. , Reuter , V. E. , Adluri , S. , Hamilton , W. B. , Lloyd , K. O. and Livingston , P. O. 1997 . Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides . Int. J. Cancer , 73 : 42 – 49 .
   PubMed Web of Science ®Google Scholar
• Ragupathi , G. , Park , T. K. , Zhang , S. , Kim , I. J. , Graber , L. , Adluri , S. , Lloyd , K. O. , Danishefsky , S. J. and Livingston , P. O. 1997 . Immunization of mice with a fully synthetic Globo H antigen results in antibodies against human cancer cells: a combined chemical—immunological approach to the fashioning of an anticancer vaccine . Angew. Chem. Int. Ed. , 36 : 125 – 128 .
   Web of Science ®Google Scholar
• Park , T. Y. , Kim , I. J. , Hu , S. , Bilodeau , M. T. , Randolph , J. T. , Kwon , O. and Danishefsky , S. J. 1996 . Total synthesis and proof of structure of a human breast tumor (Globo H) antigen . J. Am. Chem. Soc. , 118 : 11488 – 11500 .
   Web of Science ®Google Scholar
• Ragupathi , G. , Slovin , S. F. , Adluri , S. , Sames , D. , Kim , I. J. , Kim , H. M. , Spassova , M. , Bornmann , W. G. , Lloyd , K. O. , Scher , H. I. , Livingston , P. O. and Danishefsky , S. J. 1999 . A fully synthetic Globo H carbohydrate vaccine induces a focused humoral response in prostate cancer patients: a proof of principle . Angew. Chem. Int. Ed. , 38 : 563 – 566 .
   PubMed Web of Science ®Google Scholar
• Slovin , S. F. , Ragupathi , G. , Adluri , S. , Ungers , G. , Terry , K. , Kim , S. , Spassova , M. , Bornmann , W. G. , Fazzari , M. , Dantis , L. , Olkiewicz , K. , Lloyd , K. O. , Livingston , P. O. , Danishefsky , S. J. and Scher , H. I. 1999 . Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic Globo H hexasaccharide conjugate in man . Proc. Natl. Acad. Sci. USA , 96 : 5710 – 5715 .
   PubMed Web of Science ®Google Scholar
• Gilewski , T. , Ragupathi , G. , Bhuta , S. , Williams , L. J. , Musselli , C. , Zhang , X.-F. , Bencsath , K. P. , Panageas , K. S. , Chin , J. , Hudis , C. A. , Norton , L. , Houghton , A. N. , Livingston , P. O. and Danishefsky , S. J. 2001 . Immunization of metastatic breast cancer patients with a fully synthetic Globo H conjugate: a phase I trial . Proc. Nat. Acad. Sci. USA , 98 : 3270 – 3275 .
   PubMed Web of Science ®Google Scholar
• Livingston , P. , Zhang , S. , Adluri , S. , Yao , T. J. , Graeber , L. , Ragupathi , G. , Helling , F. and Fleisher , M. 1997 . Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies . Cancer Immunol. Immunother. , 43 : 324 – 330 .
   PubMed Web of Science ®Google Scholar
• Kirkwood , J. M. , Ibrahim , J. G. , Sosman , J. A. , Sondak , V. K. , Agarwala , S. S. , Ernstoff , M. S. and Rao , U. 2001 . High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIb-III melanoma: results of intergroup trial E1694/S9512/C509801 . J. Clin. Oncol. , 19 : 2370 – 2380 .
   PubMed Web of Science ®Google Scholar
• Eggermont , A. M. , Suciu , S. , Rutkowski , P. , Marsden , J. , Testori , A. , Corrie , P. , Aamdal , S. , Ascierto , P. A. , Spatz , A. and Group , E. M. 2010 . Randomized phase III trial comparing postoperative adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation in stage II (T3-T4N0M0) melanoma: final results of study EORTC 18961 . J. Clin. Oncol. , 28 ( 15 ) suppl 8505
   Google Scholar
• Itzkowitz , S. H. 1992 . Blood group-related carbohydrate antigen expression in malignant and premalignant colonic neoplasms . J. Cell Biochem. Suppl. , 16G : 97 – 101 .
   Google Scholar
• Fukushima , K. 1991 . Expression of Lewis(x), sialylated Lewis(x), Lewis(a), and sialylated Lewis(a) antigens in human lung carcinoma . Tohoku J. Exp. Med. , 163 : 17 – 30 .
   Web of Science ®Google Scholar
• Larrain , M. I. , Demichelis , S. , Crespo , M. , Lacunza , E. , Barbera , A. , Creton , A. , Terrier , F. , Segal-Eiras , A. and Croce , M. V. 2009 . Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with mucin 1 (MUC1) . J. Exp. Clin. Cancer Res. , 28 : 121
   Google Scholar
• Myers , R. B. , Srivastava , S. and Grizzle , W. E. 1995 . Lewis y antigen as detected by the monoclonal antibody br96 is expressed strongly in prostatic adenocarcinoma . J. Urol. , 153 : 1572 – 1574 .
   PubMed Web of Science ®Google Scholar
• Yin , B. W. , Finstad , C. L. , Kitamura , K. , Federici , M. G. , Welshinger , M. , Kudryashov , V. , Hoskins , W. J. , Welt , S. and Lloyd , K. O. 1996 . Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer . Int. J. Cancer , 65 : 406 – 412 .
   Web of Science ®Google Scholar
• Federici , M. F. , Kudryashov , V. , Saigo , P. E. , Finstad , C. L. and Lloyd , K. O. 1999 . Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression . Int. J. Cancer , 81 : 193 – 198 .
   Web of Science ®Google Scholar
• Buskas , T. , Li , Y. and Boons , G.-J. 2004 . The immunogenicity of the tumor-associated antigen lewisy may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein . Chem. Eur. J. , 10 : 3517 – 3524 .
   PubMed Web of Science ®Google Scholar
• Danishefsky , S. J. , Behar , V. , Randolph , J. T. and Lloyd , K. 1995 . Application of the glycal assembly method to the concise synthesis of neoglycoconjugates of Ley and Leb blood group determinants and of H-type I and H-type II oligosaccharides . J. Am. Chem. Soc. , 117 : 5701 – 5711 .
   Web of Science ®Google Scholar
• Kudryashov , V. , Kim , H. M. , Ragupathi , G. , Danishefsky , S. J. , Livingston , P. O. and Lloyd , K. O. 1998 . Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: towards the design of anticancer vaccines . Cancer Immunol. Immunother. , 45 : 281 – 286 .
   PubMed Web of Science ®Google Scholar
• Sabbatini , P. J. , Kudryashov , V. , Ragupathi , G. , Danishefsky , S. J. , Livingston , P. O. , Bornmann , W. , Spassova , M. , Zatorski , A. , Spriggs , D. , Aghajanian , C. , Soignet , S. , Peyton , M. , O’Flaherty , C. , Curtin , J. and Lloyd , K. O. 2000 . Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial . Int. J. Cancer , 87 : 79 – 85 .
   PubMed Web of Science ®Google Scholar
• Buskas , T. , Li , Y. and Boons , G. J. 2005 . Synthesis of a dimeric Lewis antigen and the evaluation of the epitope specificity of antibodies elicited in mice . Chem. Eur. J. , 11 : 5457 – 5467 .
   Web of Science ®Google Scholar
• Kim , Y. S. , Yuan , M. , Itzkowitz , S. H. , Sun , Q. B. , Kaizu , T. , Palekar , A. , Trump , B. F. and Hakomori , S. 1986 . Expression of Ley and extended Ley blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues . Cancer Res. , 46 : 5985 – 5992 .
   PubMed Web of Science ®Google Scholar
• Ragupathi , G. , Deshpande , P. P. , Coltart , D. M. , Kim , H. M. , Williams , L. J. , Danishefsky , S. J. and Livingston , P. O. 2002 . Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies . Int. J. Cancer , 99 : 207 – 212 .
   Web of Science ®Google Scholar
• Macher , B. A. , Pacuszka , T. , Mullin , B. R. , Sweeley , C. C. , Brady , R. O. and Fishman , P. H. 1979 . Isolation and identification of a fucose-containing ganglioside from bovine thyroid gland . Biochim. Biophys. Acta. , 588 : 35 – 43 .
   Web of Science ®Google Scholar
• Nilsson , O. , Brezicka , F. T. , Holmgren , J. , Sorenson , S. , Svennerholm , L. , Yngvason , F. and Lindholm , L. 1986 . Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1 . Cancer Res. , 46 : 1403 – 1407 .
   PubMed Web of Science ®Google Scholar
• Cappello , S. , Liu , N. X. , Musselli , C. , Brezicka , F. T. , Livingston , P. O. and Ragupathi , G. 1999 . Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells . Cancer Immunol. Immunother. , 48 : 483 – 492 .
   Web of Science ®Google Scholar
• Dickler , M. N. , Ragupathi , G. , Liu , N. X. , Musselli , C. , Martino , D. J. , Miller , V. A. , Kris , M. G. , Brezicka , F. T. , Livingston , P. O. and Grant , S. C. 1999 . Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer . Clin. Cancer Res. , 5 : 2773 – 2779 .
   PubMed Web of Science ®Google Scholar
• Krug , L. M. , Ragupathi , G. , Hood , C. , Kris , M. G. , Miller , V. A. , Allen , J. R. , Keding , S. J. , Danishefsky , S. J. , Gomez , J. , Tyson , L. , Pizzo , B. , Baez , V. and Livingston , P. O. 2004 . Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin . Clin. Cancer Res. , 10 : 6094 – 6100 .
   PubMed Web of Science ®Google Scholar
• Gendler , S. J. , Lancaster , C. A. , Taylor-Papadimitriou , J. , Duhig , T. , Peat , N. , Burchell , J. , Pemberton , L. , Lalani , E. N. and Wilson , D. 1990 . Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin . J. Biol. Chem. , 265 : 15286 – 15293 .
   PubMed Web of Science ®Google Scholar
• Hanisch , F. G. and Ninkovic , T. 2006 . Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptide-based tumor vaccine . Curr. Protein Pept. Sci. , 7 : 307 – 315 .
   Web of Science ®Google Scholar
• Gaidzik , N. , Kaiser , A. , Kowalczyk , D. , Westerlind , U. , Gerlitzki , B. , Sinn , H. P. , Schmitt , E. and Kunz , H. 2011 . Synthetic antitumor vaccines containing MUC1 glycopeptides with two immunodominant domains-induction of a strong immune response against breast tumor tissues . Angew. Chem. Int. Ed. , 50 : 9977 – 9981 . and references cited therein
   Web of Science ®Google Scholar
• Sorensen , A. L. , Reis , C. A. , Tarp , M. A. , Mandel , U. , Ramachandran , K. , Sankaranarayanan , V. , Schwientek , T. , Graham , R. , Taylor-Papadimitriou , J. , Hollingsworth , M. A. , Burchell , J. and Clausen , H. 2006 . Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance . Glycobiology , 16 : 96 – 107 .
   PubMed Web of Science ®Google Scholar
• Kagan , E. , Ragupathi , G. , Yi , S. S. , Reis , C. A. , Gildersleeve , J. , Kahne , D. , Clausen , H. , Danishefsky , S. J. and Livingston , P. O. 2005 . Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn . Cancer Immunol. Immunother. , 54 : 424 – 430 .
   PubMed Web of Science ®Google Scholar
• Julien , S. , Picco , G. , Sewell , R. , Vercoutter-Edouart , A. S. , Tarp , M. , Miles , D. , Clausen , H. , Taylor-Papadimitriou , J. and Burchell , J. M. 2009 . Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model . Br. J. Cancer , 100 : 1746 – 1754 .
   Web of Science ®Google Scholar
• Slovin , S. F. , Ragupathi , G. , Musselli , C. , Olkiewicz , K. , Verbel , D. , Kuduk , S. D. , Schwarz , J. B. , Sames , D. , Danishefsky , S. , Livingston , P. O. and Scher , H. I. 2003 . Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with a-N-acetylgalactosamine-O-serine/threonine conjugate vaccine . J. Clin. Oncol. , 21 : 4292 – 4298 .
   PubMed Web of Science ®Google Scholar
• Ragupathi , G. , Howard , L. , Cappello , S. , Koganty , R. R. , Qiu , D. , Longenecker , B. M. , Reddish , M. A. , Lloyd , K. O. and Livingston , P. O. 1999 . Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells . Cancer Immunol. Immunother. , 48 : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Slovin , S. F. , Ragupathi , G. , Musselli , C. , Fernandez , C. , Diani , M. , Verbel , D. , Danishefsky , S. , Livingston , P. and Scher , H. I. 2005 . Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer . Cancer Immunol. Immunother. , 54 : 694 – 702 .
   PubMed Web of Science ®Google Scholar
• Ragupathi , G. , Koide , F. , Sathyan , N. , Kagan , E. , Spassova , M. , Bornmann , W. , Gregor , P. , Reis , C. A. , Clausen , H. , Danishefsky , S. J. and Livingston , P. O. 2003 . A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers . Cancer Immunol. Immunother. , 52 : 608 – 616 .
   PubMed Web of Science ®Google Scholar
• Sabbatini , P. J. , Ragupathi , G. , Hood , C. , Aghajanian , C. A. , Juretzka , M. , Iasonos , A. , Hensley , M. L. , Spassova , M. K. , Ouerfelli , O. , Spriggs , D. R. , Tew , W. P. , Konner , J. , Clausen , H. , Abu Rustum , N. , Dansihefsky , S. J. and Livingston , P. O. 2007 . Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer . Clin. Cancer Res. , 13 : 4170 – 4177 .
   PubMed Web of Science ®Google Scholar
• Ragupathi , G. , Koide , F. , Livingston , P. O. , Cho , Y. S. , Endo , A. , Wan , Q. , Spassova , M. K. , Keding , S. J. , Allen , J. , Ouerfelli , O. , Wilson , R. M. and Danishefsky , S. J. 2006 . Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates . J. Am. Chem. Soc. , 128 : 2715 – 2725 .
   PubMed Web of Science ®Google Scholar
• Zhu , J. , Wan , Q. , Ragupathi , G. , George , C. M. , Livingston , P. O. and Danishefsky , S. J. 2009 . Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains . J. Am. Chem. Soc. , 131 : 4151 – 4158 .
   PubMed Web of Science ®Google Scholar
• Lee , D. and Danishefsky , S. J. 2009 . “Biologic” Level structures through chemistry: a total synthesis of a unimolecular pentavalent MUC1 glycopeptide construct . Tetrahedron Lett , 50 : 2167 – 2170 .
   PubMed Web of Science ®Google Scholar
• Goldman , B. and DeFrancesco , L. 2009 . The cancer vaccine roller coaster . Nature Biotech. , 27 : 129 – 139 .
   PubMed Web of Science ®Google Scholar
• Geyer , H. , Wuhrer , M. , Kurokawa , T. and Geyer , R. 2004 . Characterization of keyhole limpet hemocyanin (KLH) glycans sharing a carbohydrate epitope with schistosoma mansoni glycoconjugates . Micron , 35 : 105 – 106 .
   Web of Science ®Google Scholar
• Roldao , A. , Mellado , M. C. , Castilho , L. R. , Carrondo , M. J. and Alves , P. M. 2010 . Virus-like particles in vaccine development . Expert Rev Vaccines , 9 : 1149 – 1176 .
   PubMed Web of Science ®Google Scholar
• Lin , T. , Chen , Z. , Usha , R. , Stauffacher , C. V. , Dai , J.-B. , Schmidt , T. and Johnson , J. E. 1999 . The refined crystal structure of cowpea mosaic virus at 2.8 Å resolution . Virology , 265 : 20 – 34 .
   PubMed Web of Science ®Google Scholar
• Miermont , A. , Barnhill , H. , Strable , E. , Lu , X. , Wall , K. A. , Wang , Q. , Finn , M. G. and Huang , X. 2008 . Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines . Chem. Eur. J. , 14 : 4939 – 4947 .
   PubMed Web of Science ®Google Scholar
• Gupta , S. S. , Kuzelka , J. , Singh , P. , Lewis , W. G. , Manchester , M. and Finn , M. G. 2005 . Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold . Bioconjugate Chem. , 16 : 1572 – 1579 .
   PubMed Web of Science ®Google Scholar
• Chatterji , A. , Ochoa , W. , Shamieh , L. , Salakian , S. P. , Wong , S. M. , Clinton , G. , Ghosh , P. , Lin , T. and Johnson , J. E. 2004 . Chemical conjugation of heterologous proteins on the surface of cowpea mosaic virus . Bioconjugate Chem. , 15 : 807 – 813 .
   Web of Science ®Google Scholar
• Chatterji , A. , Ochoa , W. F. , Paine , M. , Ratna , B. R. , Johnson , J. E. and Lin , T. 2004 . New addresses on an addressable virus nanoblock: uniquely reactive lys residues on cowpea mosaic virus . Chem. Biol. , 11 : 855 – 863 .
   PubMed Web of Science ®Google Scholar
• Kaltgrad , E. , Sen Gupta , S. , Punna , S. , Huang , C. Y. , Chang , A. , Wong , C. H. , Finn , M. G. and Blixt , O. 2007 . Anti-carbohydrate antibodies elicited by polyvalent display on a viral scaffold . ChemBiochem , 8 : 1455 – 1462 .
   PubMed Web of Science ®Google Scholar
• Cobb , B. A. and Kasper , D. L. 2005 . Zwitterionic capsular polysaccharides: the new MHC II-dependent antigens . Cell Microbiol. , 7 : 1398 – 1403 .
   PubMed Web of Science ®Google Scholar
• Tzianabos , A. , Wang , J. Y. and Kasper , D. L. 2003 . Biological chemistry of immunomodulation by zwitterionic polysaccharides . Carbohydr. Res. , 338 : 2531 – 2538 .
   PubMed Web of Science ®Google Scholar
• Wang , Q. , McLoughlin , R. M. , Cobb , B. A. , Charrel-Dennis , M. , Zaleski , K. J. , Golenbock , D. , Tzianabos , A. O. and Kasper , D. L. 2006 . A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2 . J. Exp. Med. , 203 : 2853 – 2863 .
   PubMed Web of Science ®Google Scholar
• De Silva , R. A. , Wang , Q. , Chidley , T. , Appulage , D. K. and Andreana , P. R. 2009 . Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PSA1 conjugates . J. Am. Chem. Soc. , 131 : 9622 – 9623 .
   PubMed Web of Science ®Google Scholar
• Herzenberg , L. A. , Tokuhisa , T. and Herzenberg , L. A. 1980 . Carrier-priming leads to hapten-specific suppression . Nature , 285 : 664 – 667 .
   PubMed Web of Science ®Google Scholar
• Schutze , M. P. , Leclerc , C. , Jolivet , M. , Audibert , F. and Chedid , L. 1985 . Carrier-induced epitopic suppression, a major issue for future synthetic vaccines . J. Immunol. , 135 : 2319 – 2322 .
   PubMed Web of Science ®Google Scholar
• Posnett , D. N. , McGrath , H. and Tam , J. P. 1988 . A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain . J. Biol. Chem. , 263 : 1719 – 1725 .
   PubMed Web of Science ®Google Scholar
• Bay , S. , Lo-Man , R. , Osinaga , E. , Nakada , H. , Leclerc , C. and Cantacuzene , D. 1997 . Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine . J. Pept. Res. , 49 : 620 – 625 .
   PubMedGoogle Scholar
• Lo-Man , R. , Vichier-Guerre , S. , Bay , S. , Deriaud , E. , Cantacuzene , D. and Leclerc , C. 2001 . Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope . J. Immunol. , 166 : 2849 – 2854 .
   Web of Science ®Google Scholar
• Lo-Man , R. , Vichier-Guerre , S. , Perraut , R. , Deriaud , E. , Huteau , V. , BenMohamed , L. , Diop , O. M. , Livingston , P. O. , Bay , S. and Leclerc , C. 2004 . A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates . Cancer Res. , 64 : 4987 – 4994 .
   PubMed Web of Science ®Google Scholar
• Freire , T. , Zhang , X. , Deriaud , E. , Ganneau , C. , Vichier-Guerre , S. , Azria , E. , Launay , O. , Lo-Man , R. , Bay , S. and Leclerc , C. 2010 . Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant . Blood , 116 : 3526 – 3536 .
   Web of Science ®Google Scholar
• Deres , K. , Schild , H. , Wiesmuller , K. H. , Jung , G. and Rammensee , H. G. 1989 . In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine . Nature , 342 : 561 – 564 .
   PubMed Web of Science ®Google Scholar
• Toyokuni , T. , Dean , B. , Cai , S. , Boivin , D. , Hakomori , S. and Singhal , A. K. 1994 . Synthetic vaccines: synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins . J. Am. Chem. Soc. , 116 : 395 – 396 .
   Web of Science ®Google Scholar
• Wang , Q. , Zhou , Z. , Tang , S. and Guo , Z. 2012 . Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse . ACS Chem. Biol. , published online. DOI: 10.1021/cb200358r
   Web of Science ®Google Scholar
• Buskas , T. , Ingale , S. and Boons , G.-J. 2005 . Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen . Angew. Chem. Int. Ed. , 44 : 5985 – 5988 .
   PubMed Web of Science ®Google Scholar
• Ingale , S. , Wolfert , M. A. , Gaekwad , J. , Buskas , T. and Boons , G.-J. 2007 . Robust immune responses elicited by a fully synthetic three-component vaccine . Nature Chem. Biol. , 3 : 663 – 667 .
   PubMed Web of Science ®Google Scholar
• Ingale , S. , Wolfert , M. A. , Buskas , T. and Boons , G.-J. 2009 . Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors . ChemBiochem , 10 : 455 – 463 .
   Web of Science ®Google Scholar
• Sarkar , S. , Lombardo , S. A. , Herner , D. N. , Talan , R. S. , Wall , K. A. and Sucheck , S. J. 2010 . Synthesis of a single molecule L-rhamnose-containing three component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies . J. Am. Chem. Soc. , 132 : 17236 – 17246 .
   Web of Science ®Google Scholar
• Kaiser , A. , Gaidzik , N. , Becker , T. , Menge , C. , Groh , K. , Cai , H. , Li , Y. M. , Gerlitzki , B. , Schmitt , E. and Kunz , H. 2010 . Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2 . Angew. Chem. Int. Ed. , 49 : 3688 – 3692 .
   PubMed Web of Science ®Google Scholar
• Wilkinson , B. L. , Malins , L. R. , Chun , C. K. and Payne , R. J. 2010 . Synthesis of MUC1-lipopeptide chimeras . Chem. Commun. , 46 : 6249 – 6251 .
   PubMed Web of Science ®Google Scholar
• Wilkinson , B. L. , Day , S. , Malins , L. R. , Apostolopoulos , V. and Payne , R. J. 2011 . Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer . Angew. Chem. Int. Ed. , 50 : 1635 – 1639 .
   PubMed Web of Science ®Google Scholar
• Renaudet , O. , BenMohamed , L. , Dasgupta , G. , Bettahi , I. and Dumy , P. 2008 . Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine . ChemMedChem , 3 : 737 – 741 .
   PubMed Web of Science ®Google Scholar
• Bettahi , I. , Dasgupta , G. , Renaudet , O. , Chentoufi , A. A. , Zhang , X. , Carpenter , D. , Yoon , S. , Dumy , P. and BenMohamed , L. 2009 . Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes . Cancer Immunol. Immunother. , 58 : 187 – 200 .
   PubMed Web of Science ®Google Scholar
• Renaudet , O. , Dasgupta , G. , Bettahi , I. , Shi , A. , Nesburn , A. B. , Dumy , P. and BenMohamed , L. 2010 . Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity . PLoS One , 5 : e11216
   PubMed Web of Science ®Google Scholar